CRISPR patent “case of the year” hearing is a must-watch – and not just for the life sciences
Reset password
Register to access two of our subscriber only articles per month.
Register
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Subscribe
Author | Life sciences reporter
[email protected]
@IAM_Alerts Dozens of tech businesses have promised to track patenting performance among women and other under-represented inve… https://t.co/QfoyynVQpn Read more
@IAM_Alerts The only major innovators that sit outside Via's new pool seem to be Qualcomm and Technicolor… https://t.co/CUiy0mtnK1 Read more
@IAM_Alerts This looks to be far more significant than the news out of South Africa earlier in the week … https://t.co/BOkuv5fdEk Read more
@IAM_Alerts Nokia’s second quarter financials show its IP licensing business operating on margins that far exceed those of the… https://t.co/2z4VDmkUxz Read more
